DO NOT PRESCRIBE (DNP)6: NICE TA222: Ovarian cancer relapsed - not recommended with pegylated liposomal doxorubicin for relapsed platinum sensitive ovarian cancer.
DO NOT PRESCRIBE (DNP)6: NICE TA 389: Trabectedin with pegylated liposomal doxorubicin hydrochloride is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer. TA 389 replaces TA222. (Decision date - May 2016).
